A recent study investigating the immune cell transcriptome profiles of COVID-19 patients with pneumonia identified CCR4 expression as an upregulated target relative to healthy controls (De Basi et al., 2020). This evidence concerns the gene CCR4 and susceptibility to pneumonia measurement.